| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Qi F et al. | Deciphering the late steps of rifamycin biosynthesis. | 2018 | Nat Commun | pmid:29904078 |
| Lei C et al. | A feedback regulatory model for RifQ-mediated repression of rifamycin export in Amycolatopsis mediterranei. | 2018 | Microb. Cell Fact. | pmid:29375035 |
| Peano C et al. | Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineering. | 2014 | Metab. Eng. | pmid:25149266 |
| Spanogiannopoulos P et al. | A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:24778229 |
| Bapat PM et al. | Role of extracellular protease in nitrogen substrate management during antibiotic fermentation: a process model and experimental validation. | 2011 | Appl. Microbiol. Biotechnol. | pmid:21573685 |
| Verma M et al. | Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699. | 2011 | J. Bacteriol. | pmid:21914879 |
| Yuan H et al. | Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B. | 2011 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:21986914 |
| Mahalaxmi Y et al. | Development of balanced medium composition for improved rifamycin B production by isolated Amycolatopsis sp. RSP-3. | 2009 | Lett. Appl. Microbiol. | pmid:19793193 |
| Priscila G et al. | Expression of the bacterial hemoglobin gene from Vitreoscilla stercoraria increases rifamycin B production in Amycolatopsis mediterranei. | 2008 | J. Biosci. Bioeng. | pmid:19111646 |
| Doan XT et al. | Detection of phase shifts in batch fermentation via statistical analysis of the online measurements: a case study with rifamycin B fermentation. | 2007 | J. Biotechnol. | pmid:17673325 |
| Bapat PM et al. | Structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation. | 2006 | Biotechnol. Bioeng. | pmid:16302259 |
| Bapat PM et al. | Phase shifts in the stoichiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online. | 2006 | J. Biotechnol. | pmid:16904217 |
| Bapat PM et al. | A cybernetic model to predict the effect of freely available nitrogen substrate on rifamycin B production in complex media. | 2006 | Appl. Microbiol. Biotechnol. | pmid:16534611 |
| Xiong Y et al. | A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699. | 2005 | Chembiochem | pmid:15791687 |
| Hartung IV et al. | Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesis. | 2005 | J. Am. Chem. Soc. | pmid:16089423 |
| Bapat PM and Wangikar PP | Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach. | 2004 | Biotechnol. Bioeng. | pmid:15052640 |
| Jin ZH et al. | Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei. | 2004 | J. Zhejiang Univ. Sci. | pmid:15547969 |
| Xu J et al. | Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699. | 2003 | Arch. Biochem. Biophys. | pmid:12623077 |
| El-Enshasy HA et al. | Improvement of rifemycins production by Amycolatopsis mediterranei in batch and fed-batch cultures. | 2003 | Acta Microbiol. Pol. | pmid:14743983 |
| Stratmann A et al. | New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways. | 2002 | J. Antibiot. | pmid:12061548 |
| Jin ZH et al. | Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening. | 2002 | J. Gen. Appl. Microbiol. | pmid:12682871 |
| Rasalkar AA et al. | Solid state cultivation of Curvularia lunata for transformation of rifamycin B to S. | 2002 | Indian J. Exp. Biol. | pmid:12597025 |
| Floss HG | Antibiotic biosynthesis: from natural to unnatural compounds. | 2001 | J. Ind. Microbiol. Biotechnol. | pmid:11780790 |
| Doi-Katayama Y et al. | Thioesterases and the premature termination of polyketide chain elongation in rifamycin B biosynthesis by Amycolatopsis mediterranei S699. | 2000 | J. Antibiot. | pmid:10908112 |
| Courtois A et al. | Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells. | 1999 | Cancer Lett. | pmid:10408915 |
| Courtois A et al. | Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells. | 1999 | Life Sci. | pmid:10075109 |
| Stratmann A et al. | Intermediates of rifamycin polyketide synthase produced by an Amycolatopsis mediterranei mutant with inactivated rifF gene. | 1999 | Microbiology (Reading, Engl.) | pmid:10627035 |
| MejÃa A et al. | Overproduction of rifamycin B by Amycolatopsis mediterranei and its relationship with the toxic effect of barbital on growth. | 1998 | J. Antibiot. | pmid:9531988 |
| Tang L et al. | Characterization of the enzymatic domains in the modular polyketide synthase involved in rifamycin B biosynthesis by Amycolatopsis mediterranei. | 1998 | Gene | pmid:9729415 |
| Abu-Shady MR et al. | Studies of rifamycin production by Amycolatopsis mediterranei cells immobilized on glass wool. | 1995 | J. Basic Microbiol. | pmid:8568638 |
| Ward TJ et al. | Enantiomeric resolution using the macrocyclic antibiotics rifamycin B and rifamycin SV as chiral selectors for capillary electrophoresis. | 1995 | J Chromatogr A | pmid:8520671 |
| Lee KJ and Rho YT | Quantitative analysis of mycelium morphological characteristics and rifamycin B production using Nocardia mediterranei. | 1994 | J. Biotechnol. | pmid:7765266 |
| Armstrong DW et al. | Use of a macrocyclic antibiotic, rifamycin B, and indirect detection for the resolution of racemic amino alcohols by CE. | 1994 | Anal. Chem. | pmid:8030783 |
| Banerjee UC | Studies on rifamycin oxidase immobilized on kappa-carrageenan gel. | 1993 | Biomater Artif Cells Immobilization Biotechnol | pmid:8117856 |
| Banerjee UC | Characterization of rifamycin oxidase immobilized on alginate gel. | 1993 | Biomater Artif Cells Immobilization Biotechnol | pmid:8117857 |
| Korfmacher WA et al. | Characterization of three rifamycins via electrospray mass spectrometry and HPLC-thermospray mass spectrometry. | 1993 | J Chromatogr Sci | pmid:8120121 |
| Banerjee UC | Transformation of rifamycin B with growing and resting cells of Curvularia lunata. | 1993 | Enzyme Microb. Technol. | pmid:7764294 |
| Meier RM and Tamm C | Studies directed towards the biosynthesis of the C7N-unit of rifamycin B: incorporation of [14C(G)]quinic acid and [1,2-13C2]glycerol. | 1992 | J. Antibiot. | pmid:1577667 |
| Vohra RM | Novel assay for screening rifamycin B-producing mutants. | 1992 | Appl. Environ. Microbiol. | pmid:1539986 |
| Bushueva OA et al. | [Effect of low molecular weight regulators on the biosynthesis of rifamycin B by Amycolatopsis mediterranei strains]. | 1991 | Antibiot. Khimioter. | pmid:1877868 |
| Kuz'mina LM et al. | [Method for developing a controlled process. Study of the possible regulation of rifamycin B biosynthesis]. | 1990 | Antibiot. Khimioter. | pmid:2285341 |
| Kuz'mina LM et al. | [A method for developing a controlled process. Development and execution of a program supplying culture medium components for rifamycin B biosynthesis]. | 1990 | Antibiot. Khimioter. | pmid:2285343 |
| Gygax D et al. | Study to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. | 1990 | J. Antibiot. | pmid:2324014 |
| Lysko AV and Gorskaia SV | [Effect of various forms of inorganic nitrogen on the biosynthesis of rifamycin B]. | 1986 | Antibiot. Med. Biotekhnol. | pmid:3767329 |
| Han MH et al. | Rifamycin B oxidase from Monocillium spp., a new type of diphenol oxidase. | 1983 | FEBS Lett. | pmid:6825839 |
| Kawaki H et al. | Studies on quantitative structure-activity relationships. V. QSAR investigations of rifamycin B amides and hydrazides by utilization of the substituent entropy constant sigma s degrees. | 1983 | Chem. Pharm. Bull. | pmid:6850931 |
| Chertov OIu et al. | [RNA polymerase-rifamycin. A molecular model of inhibition]. | 1983 | Bioorg. Khim. | pmid:6207842 |
| Birlova LV et al. | [Stability of rifamycin B in aqueous solutions]. | 1983 | Antibiotiki | pmid:6625547 |
| Seong BL et al. | Microbial transformation of rifamycin B: a new synthetic approach to rifamycin derivatives. | 1983 | J. Antibiot. | pmid:6685721 |
| Ghisalba O et al. | Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis. | 1982 | J. Antibiot. | pmid:7200089 |
| KLUEPFEL D et al. | METABOLISM OF BARBITAL BY STREPTOMYCES MEDITERRANEI. | 1965 | Appl Microbiol | pmid:14339268 |
| GIUNCHI G | The rifamycins. | 1963 | Antibiot Chemother | pmid:13948282 |
| MARGALITH P and PAGANI H | Rifomycin. XIV. Production of rifomycin B. | 1961 | Appl Microbiol | pmid:13766661 |
| pmid: |
RIFAMYCIN B
RIFAMYCIN B is a lipid of Polyketides (PK) class. Rifamycin b is associated with abnormalities such as Tuberculosis, Leprosy and Mycobacterium Infections. The involved functions are known as Anabolism, Stereochemistry, Obstruction and Mutation. Rifamycin b often locates in Chromosomes. The associated genes with RIFAMYCIN B are RNF34 gene and Gene Clusters.
Cross Reference
Introduction
To understand associated biological information of RIFAMYCIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with RIFAMYCIN B?
RIFAMYCIN B is suspected in Tuberculosis, Leprosy, Mycobacterium Infections and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with RIFAMYCIN B
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with RIFAMYCIN B?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with RIFAMYCIN B?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with RIFAMYCIN B?
There are no associated biomedical information in the current reference collection.
What genes are associated with RIFAMYCIN B?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with RIFAMYCIN B?
There are no associated biomedical information in the current reference collection.